Review



mpm cell line msto211h  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC mpm cell line msto211h
    Mpm Cell Line Msto211h, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 584 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpm cell line msto211h/product/ATCC
    Average 96 stars, based on 584 article reviews
    mpm cell line msto211h - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    mpm cell line msto211h  (ATCC)
    96
    ATCC mpm cell line msto211h
    Mpm Cell Line Msto211h, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpm cell line msto211h/product/ATCC
    Average 96 stars, based on 1 article reviews
    mpm cell line msto211h - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    mpm cell line msto 211h  (ATCC)
    96
    ATCC mpm cell line msto 211h
    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines <t>(MSTO-211H,</t> MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.
    Mpm Cell Line Msto 211h, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpm cell line msto 211h/product/ATCC
    Average 96 stars, based on 1 article reviews
    mpm cell line msto 211h - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    mpm cell line 211h  (ATCC)
    95
    ATCC mpm cell line 211h
    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines <t>(MSTO-211H,</t> MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.
    Mpm Cell Line 211h, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpm cell line 211h/product/ATCC
    Average 95 stars, based on 1 article reviews
    mpm cell line 211h - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    mpm cell line msto 211h  (DSMZ)
    93
    DSMZ mpm cell line msto 211h
    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines <t>(MSTO-211H,</t> MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.
    Mpm Cell Line Msto 211h, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpm cell line msto 211h/product/DSMZ
    Average 93 stars, based on 1 article reviews
    mpm cell line msto 211h - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    human mpm cell lines msto 211h  (ATCC)
    96
    ATCC human mpm cell lines msto 211h
    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines <t>(MSTO-211H,</t> MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.
    Human Mpm Cell Lines Msto 211h, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human mpm cell lines msto 211h/product/ATCC
    Average 96 stars, based on 1 article reviews
    human mpm cell lines msto 211h - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    biphasic mpm cell line msto 211h  (ATCC)
    96
    ATCC biphasic mpm cell line msto 211h
    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines <t>(MSTO-211H,</t> MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.
    Biphasic Mpm Cell Line Msto 211h, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biphasic mpm cell line msto 211h/product/ATCC
    Average 96 stars, based on 1 article reviews
    biphasic mpm cell line msto 211h - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    pleural mpm cell lines msto 211  (ATCC)
    96
    ATCC pleural mpm cell lines msto 211
    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines <t>(MSTO-211H,</t> MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.
    Pleural Mpm Cell Lines Msto 211, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pleural mpm cell lines msto 211/product/ATCC
    Average 96 stars, based on 1 article reviews
    pleural mpm cell lines msto 211 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines (MSTO-211H, MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.

    Journal: International Journal of Molecular Sciences

    Article Title: TGF-β Inhibition Through Combinatory Strategies Suppresses Proliferation and Invasiveness in Malignant Pleural Mesothelioma

    doi: 10.3390/ijms27052157

    Figure Lengend Snippet: Efficacy of TGF-β silencing and its effect on cell viability and proliferation . ( A ) Percentage of TGF-β inhibition across all MPM cell lines (MSTO-211H, MM404, MM421, MM432) following transfection with TGF-β siRNA (60 nM). Data are presented as means ± SD ( n = 3). **** p < 0.0001, *** p < 0.001: siTGF-β vs. respective Ctrl. ( B ) Evaluation of the cell proliferation marker PCNA by real-time PCR 48 h after transfection. Data are presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl. ( C ) Evaluation of cell viability via MTT assay 48 h after transfection with TGF-β siRNA (60 nM). Measurements were performed in triplicate. Data are expressed as percentage of viable cells relative to control and presented as means ± SD ( n = 3). *** p < 0.001, ** p < 0.01: siTGF-β vs. respective Ctrl.

    Article Snippet: Experiments were performed on the commercially available MPM cell line MSTO-211H (human biphasic mesothelioma cells), purchased from American Type Culture Collection (ATCC; Manassas, VA, USA), and primary MPM patient-derived cell lines MM404 (human epithelioid histotype), MM421 (human biphasic histotype) and MM432 (human sarcomatoid histotype) from Biological Bank of Mesothelioma (SS.

    Techniques: Inhibition, Transfection, Marker, Real-time Polymerase Chain Reaction, MTT Assay, Control

    Effect of TGF-β silencing on MPM cell migration and cell cycle. ( A ) Scratch assay evaluated on MSTO-211H cells after 48 h without (-) or with 60 nM TGF-β siRNA. Cells were analyzed by microscopy at the time of scratching (T0) and after 24 h (T1). Relative migration was calculated by setting the percentage migration of control cells at T1 equal to 100% and comparing the percentage migration of cells after transfection with siTGF-β to this value. Data are presented as means ± SD. **** p < 0.0001: cells transfected with siTGF-β vs. Ctrl cells. ( B ) Cell cycle analysis using flow cytometry after staining with propidium iodide (PI). ( C ) Distribution of cells in sub-G1, G1/G0, S, and G2/M phases of the cell cycle under different experimental conditions. Data are presented as means ± SD ( n = 3). **** p < 0.0001, ** p < 0.01 and * p < 0.05: treated cells vs. respective untreated cells (Ctrl).

    Journal: International Journal of Molecular Sciences

    Article Title: TGF-β Inhibition Through Combinatory Strategies Suppresses Proliferation and Invasiveness in Malignant Pleural Mesothelioma

    doi: 10.3390/ijms27052157

    Figure Lengend Snippet: Effect of TGF-β silencing on MPM cell migration and cell cycle. ( A ) Scratch assay evaluated on MSTO-211H cells after 48 h without (-) or with 60 nM TGF-β siRNA. Cells were analyzed by microscopy at the time of scratching (T0) and after 24 h (T1). Relative migration was calculated by setting the percentage migration of control cells at T1 equal to 100% and comparing the percentage migration of cells after transfection with siTGF-β to this value. Data are presented as means ± SD. **** p < 0.0001: cells transfected with siTGF-β vs. Ctrl cells. ( B ) Cell cycle analysis using flow cytometry after staining with propidium iodide (PI). ( C ) Distribution of cells in sub-G1, G1/G0, S, and G2/M phases of the cell cycle under different experimental conditions. Data are presented as means ± SD ( n = 3). **** p < 0.0001, ** p < 0.01 and * p < 0.05: treated cells vs. respective untreated cells (Ctrl).

    Article Snippet: Experiments were performed on the commercially available MPM cell line MSTO-211H (human biphasic mesothelioma cells), purchased from American Type Culture Collection (ATCC; Manassas, VA, USA), and primary MPM patient-derived cell lines MM404 (human epithelioid histotype), MM421 (human biphasic histotype) and MM432 (human sarcomatoid histotype) from Biological Bank of Mesothelioma (SS.

    Techniques: Migration, Wound Healing Assay, Microscopy, Control, Transfection, Cell Cycle Assay, Flow Cytometry, Staining